Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Lisuride Patch to Treat Parkinson's Disease [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating a lisuride patch for Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisuride Patch (lisuride)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED